Phenotypic and functional characterization of blood γδ T cells in sleep apnea

American Journal of Respiratory and Critical Care Medicine

Volumn 168, Issue 2, 2003, Pages 242-249

  Dyugovskaya, Larissa ^a   Lavie, Peretz ^a   Lavie, Lena ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Adhesion; Cytotoxicity; Interleukin 10; Selectins; Tumor necrosis factor

Indexed keywords

CELL RECEPTOR; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULAR 1 ANTIBODY; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INHIBITORY NATURAL KILLER CELL RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 8; L SELECTIN; PADGEM PROTEIN; PADGEM PROTEIN ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ATHEROGENESIS; CELL ADHESION; CELL DAMAGE; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOPHENOTYPING; MORPHOLOGICAL TRAIT; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SLEEP APNEA SYNDROME; T LYMPHOCYTE;

ARTERIOSCLEROSIS; CASE-CONTROL STUDIES; CYTOKINES; CYTOTOXICITY TESTS, IMMUNOLOGIC; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; SLEEP APNEA, OBSTRUCTIVE;

EID: 0042165846     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200210-1226OC     Document Type: Article

References (70)

1. Lavie P, Herer P, Hoffstein V. Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ 2000;320:479-482.
2. Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Javier Nieto F, O'Connor GT, Boland LL, Schwartz JE, Samet JM for the Sleep Heart Health Study Research Group. Sleep-disordered breathing and cardiovascular disease cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001;163:19-25.
3. Malhotra A, White D. Obstructive sleep apnea. Lancet 2002;360:237-245.
4. Dyugovskaya L, Lavie P, Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 2002;165:934-939.
5. Lavie L. Obstructive sleep apnoea syndrome: an oxidative stress disorder. Sleep Med Rev 2003;7:35-51.
6. Monaco C, Andreakos E, Young S, Feldmann M, Paleolog E. T cell mediated signaling to vascular endothelium: induction of cytokines, chemokines, and tissue factor. J Leukoc Biol 2002;71:659-668.
7. Vgontzas AN, Papanicolaou DA, Bixler EO, Kales A, Tyson K, Chrousos GP. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbances and obesity. J Clin Endocrinol Metab 1997;82:1313-1316.
8. Vgontzas AN, Papanicolaou DA, Bixler EO, Hopper K, Lotsikas A, Lin HM, Kales A, Chrousos GP. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance and hypercytokinemia. J Clin Endocrinol Metab 2000;85:1151-1158.
9. Ohga E, Tomita T, Wada H, Yamamoto H, Nagase T, Ouchi Y. Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1. J Appl Physiol 2003;94:179-184.
10. Hayday AC. γδ Cells: a right time and a right place for a conserved third way of protection. Annu Rev Immunol 2000;18:975-1026.
11. Bluestone JA, Khattri R, Sciammas R, Sperling AI. TCR gamma delta cells: a specialized T cell subset in the immune system. Annu Rev Cell Dev Biol 1995;11:307-353.
12. Crowley MP, Reich Z, Mavaddat N, Altman JD, Chein Y-H. The recognition of the non-classical major histocompatibility complex (MHC) class 1 molecules, T10, by the γδ T-cell, G8. J Exp Med 1997;185:1223-1230.
13. Young AJ, Marston WL, Dudler L. Subset-specific regulation of the lymphatic exit of recirculating lymphocytes in vivo. J Immunol 2000;165:3168-3174.
14. Carding SR, Egan PJ. Gammadelta T-cells: functional plasticity and heterogeneity. Nat Rev Immunol 2002;2:336-345.
15. Song L, Leung C, Schindler C. Lymphocytes are important in early atherosclerosis. J Clin Invest 2001;108:251-259.
16. Emeson EE, Robetson AL. T lymphocytes in aortic and coronary intimas: their potential role in atherogenesis. J Pathol 1988;130:369-376.
17. Kleindienst R, Xu Q, Willeit J, Waldenberger FR, Weimann S, Wick G. Immunology of atherosclerosis: demonstration of heat shock protein 60 expression and T lymphocytes bearing alpha/beta or gamma/delta receptor in human atherosclerosic lesions. Am J Pathol 1993;142:1927-1937.
18. Wick G, Xu Q. Atherosclerosis: an autoimmune disease. Exp Gerontol 1999;34:559-566.
19. Galea P, Brezinschek R, Lipsky PE, Oppenheimer-Marks N. Phenotyic characterization of CD4-/alpha beta TCR+ and gamma delta TCR+ T cells with a transendothelial migratory capacity. J Immunol 1994;153:529-542.
20. Kahaleh MB, Fan PS, Otsuka T. Gamma/delta receptor bearing T cells in scleroderma: enhanced interaction with vascular endothelial cells in vitro. Clin Immunol 1999;91:188-195.
21. Mohagheghpour N, Bermuder LE, Khajavi S, Rivas A. The VLA-4/VCAM-1 molecules participate in gamma delta cell interaction with endothelial cells. Cell Immunol 1992;143:170-182.
22. Kretowski A, Mysliwiec J, Szelachowska M, Turowski D, Wysocka J, Kowalska I, Kinalska I. Gammadelta T cells alterations in the peripheral blood of high risk diabetes type 1 subjects with subclinical pancreatic B cell impairment. Immunol Lett 1999;68:289-293.
23. Bank I, Chohen L, Mouallem M, Ferfel Z, Grossman E, Ben-Nun A. γδ T cell subsets in patients with arthritis and chronic neutropenia. Ann Rheum Dis 2002;61:438-443.
24. Heng MK, Heng MC. Heat shock protein 65 and activated gamma/delta T cells in injured arteries. Lancet 1994;344:921-923.
25. Dyugovskaya L, Bashenko Y, Hirsh M, Krausz M. Immune potential of lymph node-derived lymphocytes in uncontrolled hemorrhagic shock. Shock 2001;15:118-123.
26. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardu C. A rapid simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 1991;139:271-279.
27. Ikuta K, Lee H-C, Ye S-K. Role of the IL-7 receptor in gamma-delta T cell development. Chem Immunol 2001;79:29-42.
28. Kato M, Roberts-Thomson P, Phillips BG, Haynes WG, Winnicki M, Accurso V, Somers VK. Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 2000;102:2607-2610.
29. Kraiczi H, Caidahl K, Samuelsson A, Peker Y, Hedner J. Impairment of vascular endothelial function and left ventricular filling: association with the severity of apnea-induced hypoxemia during sleep. Chest 2001;119:1085-1091.
30. Dean RT, Wilcox I. Possible atherogenic effects of hypoxia during obstructive sleep apnea: (supplement: 2. natural history of sleep apnea). Sleep 1993;16:S15-S22.
31. Shigematsu S, Wolf RE, Granger DN. T lymphocytes modulate the microvascular and inflammatory response to intestinal ischamia-reperfusion. Microcirculation 2002;9:99-109.
32. Hansson GK. Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol 2001;21:1876-1890.
33. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999;340:115-126.
34. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witzum JL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915-924.
35. Stemme S, Faber B, Holm J, Wiklund O, Witztum JL, Hansson GK. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci USA 1995;92:3893-3897.
36. Stemme S, Holm J, Hansson GK. T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1. Arterioscler Thromb 1992;12:206-211.
37. Van der Wal AC, Das PK, van de Berg DB, van der Loos CM, Becker AE. Atherosclerotic lesions in humans: in situ immunophenotypic analysis suggesting an immune mediated response. Lab Invest 1989;61:166-170.
38. Pober JS, Collins T, Gimbrone MA Jr, Cotran RS, Gitlin JD, Fiers W, Clayberger C, Krensky AM, Burakoff SJ, Reiss CS. Lymphocytes recognize human vascular endothelial and dermal fibroblast Ia antigens induced by recombinant immune interferon. Nature 1983;305:726-729.
39. Battistini L, Borsellino G, Sawicki G, Poccia F, Salvetti M, Ristori G, Brosnan CF. Phenotypic and cytokine analysis of human peripheral blood γδ T cells expressing NK cell receptors. J Immunol 1997;159:3723-3730.
40. Solana R, Mariani E. NK and NK/T cells in human senescence. Vaccine 2000;18:1613-1620.
41. Zheng BJ, Ng SP, Chua DT, Sham JS, Kwong DL, Lam CK, Ng MH. Peripheral gamma delta T cell deficit in nasopharyngeal carcinoma. Int J Cancer 2002;99:213-217.
42. Pittet MJ, Speiser DE, Valmori D, Cerottini J-C, Romero P. Cutting edge: cytolytic effector function in human circulating CD8+ T cells closely correlates with CD56 surface expression. J Immunol 2000;164:1148-1152.
43. Grisham MB, Granger DN, Lefer DJ. Modulation of leukocyte-endothelial interactions by reactive metabolites of oxygen and nitrogen: relevance to ischemic heart disease. Free Radic Biol Med 1998;25:404-433.
44. Walzog B, Gaehtgens P. Adhesion molecules: the path to a new understanding of acute inflammation. News Physiol Sci 2000;15:107-113.
45. Haddad JJ. Pharmaco-redox regulation of cytokine-related pathways: from receptor signaling to pharmacogenomics. Free Radic Biol Med 2002;33:907-926.
46. Kollias G, Douni E, Kassiotis G, Kontoyiannis D. On the role of tumor necrotic factor and receptors in models multiorgan failure, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease. Immunol Rev 1999;169:175-194.
47. Barath P, Fishbein MC, Cao G, Berenson L, Helfant RH, Forrester JS. Detection and localization of tumor necrotic factor in human atheroma. Am J Cardiol 1990;65:297-302.
48. Bevilacqua MP, Pober JS, Majeau GR, Fiers W, Cotran RS, Gimbrone MA. Recombinant tumor necrotic factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the action of interleukin-1. Proc Natl Acad Sci USA 1986;83:4533-4537.
49. Van Damme J, Van Beeumen J, Opdenakker G, Billau A. A novel, NH2-terminal sequence-characterized human monokine possessing neutrophil chemotactic, skin-reactive, and granulocytosis-promoting activity. J Exp Med 1988;167:1364-1376.
50. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, Elner SG, Strieter RM. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992;258:1798-1801.
51. Sebok K, Woodside D, al-Aoukaty A, Ho AD, Gluck S, Maghazachi AA. IL-8 induces the locomotion of human IL-2-activated natural killer cells: involvement of guanine nucleotide binding (Go) protein. J Immunol 1993;150:1524-1534.
52. Terkeltaub RA. 1L-10: an "immunologic scalpel" for atherosclerosis? Arterioscler Thromb Vasc Biol 1999;19:2823-2825.
53. Mallat Z, Besnard S, Duriez M, Deleuze V, Emmanuel F, Bureau MF, Soubrier F, Esposito B, Duez H, Fievet C, et al. Protective role of interleukin-10 in atherosclerosis. Circ Res 1999;85:17-24.
54. Haddad JJ, Fahlman CS. Redox- and oxidant-mediated regulation of interleukin-10: an inflammatory, antioxidant cytokine? Biochem Biophys Res Commun 2002;297:163-176.
55. Pinderski Oslund LJ, Hedrick CC, Olvera T, Hagenbaugh A, Territo M, Berliner JA, Fyfe AI. Interleukin-10 blocks atherosclerotic events in vitro and in vivo. Arterioscler Thromb Vasc Biol 1999;19:2847-2853.
56. Smith DA, Irving SD, Sheldon J, Cole D, Kaski JC. Serum level of the anti-inflammatory cytokine interleukine-10 are decreased in patients with unstable angina. Circulation 2001;104:746-749.
57. Yang Z, Zingarelli B, Szabo C. Crucial role of endogenous interleukin-10 production in myocardial ischemia/reperfusion injury. Circulation 2000;101:1019-1026.
58. Gunnett CA, Heistad DD, Berg DJ, Faraci FM. IL-10 deficiency increases superoxide and endothelial dysfunction during inflammation. Am J Physiol Heart Circ Physiol 2000;299:H1555-H1562.
59. Lafont V, Liautard J, Liautard JP, Favero J. Production of TNF-alpha by human V gamma 9V delta 2 T cells via engagement of Fc gammaRI-IIA, the low affinity type 3 receptor for the Fc portion of IgG, expressed upon TCR activation by nonpeptidic antigen. J Immunol 2001;166:7190-7199.
60. Naldini A, Carraro F, Sivestri S, Bocci V. Hypoxia affects cytokine production and proliferation response by human peripheral mononuclear cells. J Cell Physiol 1997;173:335-342.
61. Galindo M, Santiago B, Alcami J, Rivero M, Martin-Serrano J, Pablos JL. Hypoxia induces expression of the chemokines monocyte chemoattractant protein-1 (MCP-1) and IL-8 in human dermal fibroblasts. Clin Exp Immunol 2001;23:36-41.
62. Kokura S, Wolf RE, Yoshikawa T, Granger DN, Aw TY. T-lymphocyte-derived tumor necrosis factor exacerbates anoxia-reoxygenation-induced neutrophil-endothelial cell adhesion. Circ Res 2000;86:205-213.
63. Kokura S, Yoshida N, Yoshikawa T. Anoxia/reoxygenation-induced leukocyte-endothelial cell interactions. Free Radic Biol Med 2002;33:427-432.
64. Chen L, Vicaut E, Sercombe R. Polymorphonuclear leukocyte activation induces cerebral hypoperfusion in rats in the absence of previous ischemia-reperfusion. Neurosci Lett 2002;331:203-207.
65. Lofaso F, Coste A, Gilain L, Harf A, Guilleminault C, Goldenberg F. Sleep fragmentation as a risk factor for hypertension in middle aged non-apneic snorers. Chest 1996;109:896-900.
66. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES. The sympathetic nerve: an integrative interference between two supersystems: the brain and the immune system. Pharmacol Rev 2000;52:595-638.
67. Peled N, Greenberg A, Pillar G, Zinder O, Levi N, Lavie P. Contributions of hypoxia and respiratory disturbance index to sympathetic activation and blood pressure in obstructive sleep apnea syndrome. Am J Hypertens 1998;11:1284-1289.
68. Elenkov IJ, Chrousos GP, Wilder RL. Neuroendocrine regulation of IL-12 and TNF-α/IL-10 balance: clinical implications. Ann N Y Acad Sci 2000;917:94-105.
69. Schaberg T, Theilacker C, Nitschke OT, Lode H. Lymphocyte subsets in peripheral blood and smoking habits. Lung 1997;175:387-394.
70. Richmond I, Pritchard GE, Ashcroft T, Corris PA, Walters EH. Distribution of gamma delta T cells in the bronchial tree of smokers and non-smokers. J Clin Pathol 1993;46:926-930.